InfraReDx Initiates A Randomized Clinical Trial Of LipiScan IVUS™ Coronary Imaging Guidance To Prevent Heart Attacks During Stenting
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow)…
Author: admin
This author has published 36564 articles so far. More info about the author is coming soon.